SMTL ID : 6q2w.2 (1 other biounit)

Crystal structure of human ROR gamma LBD in complex with a quinoline sulfonamide inverse agonist

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.99 Å

Oligo State

monomer

Ligands

1 x HBW: (2~{S})-1-[2,4-bis(chloranyl)-3-[[4-imidazol-1-yl-2-(trifluoromethyl)quinolin-8-yl]oxymethyl]phenyl]sulfonyl-~{N}-methyl-pyrrolidine-2-carboxamide(Non-covalent)

HBW.1: 23 residues within 4Å: Chain A: Q.20, W.51, C.54, H.57, L.58, A.61, M.92, V.95, L.96, M.99, V.110, F.111, F.112, F.122, L.125, L.130, I.134, F.135, L.209, C.210, Q.212, H.213, V.214 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:W.51, A:L.58, A:A.61, A:V.95, A:V.110, A:F.122, A:L.125 Hydrogen bonds: A:Q.20, A:H.57, A:Q.212, A:H.213 Water bridges: A:E.113 Halogen bonds: A:M.92, A:C.210

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Amaudrut, J. et al., Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active ROR gamma inverse agonists. Bioorg.Med.Chem.Lett. (2019)

Release Date

2019-05-29

Peptides

Nuclear receptor ROR-gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Nuclear receptor ROR-gamma

Related Entries With Identical Sequence